MPN

>

CURE’s myeloproliferative neoplasms (MPN) page is an extensive resource of cancer information featuring the latest MPN news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on myeloproliferative neoplasms.

Latest News

Image of blood.
July Blood Cancer Highlights: Top 5 Updates Patients Should Know

July 30th 2025

As July concludes, the landscape of hematologic oncology continues to evolve, with notable progress in multiple myeloma, myelofibrosis, and CLL.

Cytopenia at myelofibrosis diagnosis raises risk of acute myeloid leukemia and lowers survival: © stock.adobe.com.
Cytopenia in Myelofibrosis Linked to Higher AML Risk, Lower Survival

July 28th 2025

Image of doctor
What Patients With Polycythemia Vera Should Know After ASCO 2025

June 21st 2025

The FDA granted fast track designation to nuvisertib for those with intermediate or high-risk myelofibrosis: © stock.adobe.com.
FDA Grants Fast Track Designation to Nuvisertib in Myelofibrosis

June 16th 2025

Image of blood cells.
Rusfertide Reduces Phlebotomy Need, Improves Quality of Life in Polycythemia Vera

June 11th 2025

Video Series
Video Interviews
Podcasts
Cancer Horizons podcast logo

More News